Castle Biosciences Wins NY Approval for AdvanceAD-Tx Test
FRIENDSWOOD, Texas, July 14, 2026 Castle Biosciences, Inc. has announced that its AdvanceAD-Tx™ test has received assay approval from...
personalized medicine
Advertisement
PreludeDx Expands DCIS Education Through New Collaboration
LAGUNA HILLS, Calif., July 7, 2026 PreludeDx™, a leader in precision diagnostics for early-stage breast cancer, has announced a...
Alcon and RxSight Partner on Adjustable PCIOL Technology
ALISO VIEJO, Calif., July 6, 2026 Alcon and RxSight, Inc. have announced a strategic collaboration to jointly develop adjustable...
Allarity Therapeutics Secures U.S. Patent for DRP® Platform
TARPON SPRINGS, Fla., June 30, 2026 Allarity Therapeutics, Inc. announced that the U.S. Patent and Trademark Office (USPTO) has...
Delphi Diagnostics Validates EAI for Paclitaxel Benefit
HOUSTON, Texas, June 22, 2026 Delphi Diagnostics has announced the publication of new clinical findings validating the predictive power...
Advertisements
Genprex Strengthens REQORSA Cancer Gene Therapy Patent
AUSTIN, Texas, June 22, 2026 Genprex, Inc. has announced a significant intellectual property milestone after receiving a Notice of...
Pierre Fabre Secures EU Approval for BRAFTOVI in mCRC
CASTRES, France, June 22, 2026 Laboratoires Pierre Fabre has received a major regulatory milestone with the European Commission approval...
US WorldMeds Secures Full FDA Approval for TECELRA
LOUISVILLE, Kentucky, June 22, 2026 US WorldMeds has announced that the U.S. Food and Drug Administration (FDA) has granted...
Teva Highlights Long-Term AUSTEDO Success in Tardive Dyskinesia Care
PARSIPPANY, N.J. and TEL AVIV, Israel, June 20, 2026 Teva Pharmaceutical Industries Ltd. has unveiled compelling new long-term data...
Curium Court Victory Clears Path for U.S. GEP-NET Therapy
BOSTON, MA, June 18, 2026 Curium™ has secured a significant legal and commercial milestone after prevailing in a patent...
Advertisement
